Skip to Content

Facts and Figures in R&D

Chart of R&D expenditures

Roche spends more than 8 billion Swiss francs on research and development and employs nearly 7000 people in R&D.

A unique R&D network model and strong alliances with companies, universities and research institutions worldwide give our scientists broadest access to innovation.

Group R&D Expenditures in millions of CHF
20072006% change
CHF		% change
LC		2007
% of sales		2006
% of sales
Group8,3857,365141618.217.5
Divisional R&D Expenditures in millions of CHF
2007% chagne
CHF		% change
LC		% of sales
Pharmaceuticals7,598151820.7
Diagnostics787218.4

Roche has 6 Pharma Research centers around the world with some 2,900 scientists passionate about discovering medicines to meet the unmet medical needs of patients.

Pharma Development has 6 centers where about 4,000 scientists and physicians design and conduct preclinical and clinical trials to transform promising compounds into clinically differentiated medicines for patients.

The Research and Development sites focus on specific Disease Biology Areas or on strategic areas of research technologies and/or specific areas in preclinical or clinical development.  They are:

LocationFocus area
Basel, Switzerland (R+D)Metabolics and Central Nervous System
Kulmbach Germany (R)RNA-based Therapeutics
Nutley (NJ), USA (R+D)Oncology and Metabolics
Palo Alto (CA), USA (R)Inflammation and Virology
Penzberg, Germany (R)Protein Therapeutics
Shanghai, China (R+D)Research and Clinical Development
Sydney, Australia (Dev.)Clinical Development Operations
Welwyn, Great Britain (Dev.)Pharmaceutical Development